Open-label Study of Adjunctive GNX Treatment in Children and Adults With TSC-related Epilepsy
A Phase 3, Open-label Study of Adjunctive Ganaxolone (GNX) Treatment in Children and Adults With Tuberous Sclerosis Complex (TSC)-Related Epilepsy (TrustTSC OLE) A Phase 3, Open-label Study of Adjunctive Ganaxolone(GNX) Treatment in Children and Adults With Tube ...
Adjunctive GNX Treatment Compared With Placebo in Children and Adults With TSC-related Epilepsy
A Phase 3, Double-blind, Randomized, Placebo-controlled Trial of Adjunctive Ganaxolone (GNX) Treatment in Children and Adults With Tuberous Sclerosis Complex (TSC)-Related Epilepsy (TrustTSC) A Phase 3, Double-blind, Randomized, Placebo-controlled Trial of Adjunctive Ganaxolone(GNX) Treatmen ...
Adjunctive Ganaxolone Treatment (Part A) in TSC Followed by Long-term Treatment (Part B)
A Phase 2 Open-label 12-Week Trial of Adjunctive Ganaxolone Treatment (Part A) in Tuberous Sclerosis Complex-related Epilepsy Followed by Long-term Treatment (Part B) A Phase 2 Open-label 12-Week Trial of Adjunctive GanaxoloneTreatment (Part A) in Tuberous Sclerosis ...